Abstract
Little is known about the association between prior gestational hyperglycemia of different severity and the subsequent risk for the metabolic syndrome. Eighty-one women with prior gestational diabetes mellitus (GDM), 25 with one abnormal value at the oral glucose tolerance test (OGTT), and 65 with normal OGTT were studied after a mean of 8.5 yr from the index pregnancy. Patients with prior gestational hyperglycemia (both one abnormal value at the OGTT and GDM) showed a worse metabolic pattern than subjects with gestational normoglycemia [respectively higher values of body mass index (BMI), waist, blood pressure, serum glucose, insulin, C-peptide, homeostatic model assessment (HOMA), fibrinogen and lower levels of HDL-cholesterol]. Prevalence of the metabolic syndrome and its components was 2–4-fold higher in women with prior gestational hyperglycemia (and 10-fold higher if pre-pregnancy obesity coexisted) when compared to normoglycemic controls; in a Cox proportional hazard model, after adjustments for age and pre-pregnancy BMI, gestational hyperglycemia and pre-pregnancy BMI predicted subsequent metabolic syndrome [respectively: hazard ratio (HR)=4.26 and HR=1.21] and most of its components. In the same model, the highest quartile of fasting serum glucose at the OGTT of the index pregnancy was significantly associated to the metabolic syndrome and its components. Gestational hyperglycemia and fasting glucose values were also associated to subsequent fibrinogen values, but not to albumin excretion rates. In young adult women, prior gestational hyperglycemia (particularly abnormal fasting glucose values), above all in combination with pre-pregnancy obesity, anticipates a subsequent syndrome at high cardiovascular risk and, possibly, a mild chronic inflammatory response.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Catalano PM, Kirwan JP, Haugel-de-Mouzon S, King J. Gestational diabetes and insulin resistance: role in short- and long-term implications for mother and fetus. J Nutr 2003, 133: 1674S–1683S.
Meyers-Seifer CH, Vohr BR. Lipid levels in former gestational diabetic mothers. Diabetes Care 1996, 19: 1351–56.
Davis CL, Gutt M, Llabre MM, et al. History of gestational diabetes, insulin resistance and coronary risk. J Diabetes Complications 1999, 4: 216–23.
Verma A, Boney CM, Tucker R, Vohr BR. Insulin resistance syndrome in women with prior history of gestational diabetes mellitus. J Clin Endocrinol Metab 2002, 87: 3227–35.
Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001, 24: 683–9.
National Institute of Health. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001, 285: 2486–97.
Alberti KGMM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med 1998, 15: 539–53.
Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982, 144: 768–73.
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28: 412–9.
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2003, 26: S5–S20.
National High Blood Pressure Education Working Group Report on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 1990, 163: 1689–712.
Clark CM, Qiu C, Amerman B, et al. Gestational diabetes: should it be added to the syndrome of insulin resistance? Diabetes Care 1997, 20: 867–71.
Martin U, Davies C, Hayavi S, Hartland A, Dunne F. Is normal pregnancy atherogenic? Clin Sci (Lond) 1999, 96: 421–5.
Sattar N, Greer IA. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? BMJ 2002, 325: 157–60.
Hermans MP, Levy JC, Morris RJ, Turner RC. Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes. Diabetologia 1999, 42: 678–87.
Ergin T, Lembet A, Duran H, et al. Does insulin secretion in patients with one abnormal glucose tolerance test value mimic gestational diabetes mellitus? Am J Obstet Gynecol 2002, 186: 204–9.
Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 2002, 25: 1862–8.
Ko GT, Chan JC, Tsang LW, Li CY, Cockram CS. Glucose intolerance and other cardiovascular risk factors in Chinese women with a history of gestational diabetes mellitus. Aust N Z J Obstet Gynaecol 1999, 39: 478–83.
Kousta E, Lawrence NJ, Godsland IF, et al. Insulin resistance and β-cell dysfunction in normoglycaemic European women with a history of gestational diabetes. Clin Endocrinol (Oxf) 2003, 59: 289–97.
Sriharan M, Reichelt AJ, Opperman MLR, et al. Total sialic acid and associated elements of the metabolic syndrome in women with and without previous gestational diabetes. Diabetes Care 2002, 25: 1331–5.
Bruno G, Cavallo-Perin P, Bargero G, et al. Hyperfibrinogenemia and metabolic syndrome in type 2 diabetes: a population-based study. Diabetes Metab Res Rev 2001, 17: 124–30.
Ford ES. The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the Third National Health and Nutrition Examination Survey. Atherosclerosis 2003, 168: 351–8.
Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999, 340: 115–26.
Retnakaran R, Hanley AJG, Raif N, Connelly PW, Sermer M, Zinman B. C-reactive protein and gestational diabetes: the central role of maternal obesity. J Clin Endocrinol Metab 2003, 88: 3507–12.
Groop L, Ekstrand A, Forsblom C, et al. Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1993, 36: 642–7.
Nielsen S, Schmitz O, Orskov H, Mogensen CE. Similar insulin sensitivity in NIDDM patients with normo- and microalbuminuria. Diabetes Care 1995, 18: 834–42.
Jagar A, Kostense PJ, Nijpels G, Heine RJ, Bouter LM, Stenhouwer CD. Microalbuminuria is strongly associated with NIDDM and hypertension, but not with the insulin resistance syndrome: the Hoorn Study. Diabetologia 1998, 41: 694–700.
Agewall S, Fagerberg B, Attvall S. Microalbuminuria, insulin sensitivity and haemostatic factors in non-diabetic treated hypertensive men: Risk Factor Intervention Study Group. J Intern Med 1995, 237: 195–203.
Mikkanen L, Zaccaro DJ, Wagenknecht LE, Robbins DC, Gabriel M, Haffner SM. Microalbuminuria is associated with insulin resistance in nondiabetic subjects. The Insulin Resistance Atherosclerosis Study. Diabetes 1998, 47: 793–800.
Go RCP, Desmond R, Roseman JM, Bell DSH, Vanichanan C, Acton RT. Prevalence and risk factors of microalbuminuria in a cohort of African-American women with gestational diabetes. Diabetes Care 2001, 24: 1764–9.
Catalano PM, Vargo KM, Bernstein IM, Amini SB. Incidence and risk factors associated with abnormal postpartum glucose tolerance in women with gestational diabetes mellitus. Am J Obstet Gynecol 1991, 165: 914–9.
Pallardo F, Herranz L, Garcia-Ingelmo T, et al. Early postpartum metabolic assessment in women with prior gestational diabetes. Diabetes Care 1999, 22: 1053–8.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bo, S., Monge, L., Macchetta, C. et al. Prior gestational hyperglycemia: A long-term predictor of the metabolic syndrome. J Endocrinol Invest 27, 629–635 (2004). https://doi.org/10.1007/BF03347494
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03347494